DFX Intelligence

Data Factory

Ona Therapeutics

series b

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:dcc008d6-a31a-4904-a317-0d2ae266d60d

Data as of Sep 12, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 19, 2026, 6:01 AM UTC and rebuilt at most every 15 minutes.

Relationships: 7
Dated events: 1
On other graphs: 0
Observed: Sep 12, 2026 to Sep 12, 2026
1 observations

Across DFX

This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 1
Latest round: Series B 2026-06-04
Latest round amount: $86.6M
Total disclosed raised: $86.6Mderivedsum of disclosed round sizes only
Investors: 7
People: 0

Rounds

Announced	Round	Stage	Amount	Basis	Investors
Jun 4, 2026	Series B	Series b	$86.6M	disclosed	n/a

Investors

Investor	Class	Fund	Partner	Role	Attribution
Columbus Venture Partners	Candidate VC	n/a	n/a	participant	Unknown
Mérieux Equity Partners	Candidate VC	n/a	n/a	participant	Unknown
Korys	Candidate VC	n/a	n/a	participant	Unknown
Asabys Partners	Candidate VC	n/a	n/a	participant	Unknown
Bpifrance	Candidate VC	n/a	n/a	participant	Unknown
FundPlus NV	Candidate VC	n/a	n/a	participant	Unknown
Ysios Capital	Candidate VC	n/a	n/a	participant	Unknown

Relationships

Invested in (7)

← Columbus Venture PartnersFirmround
Jun 4, 2026 to presentfactNews and newswire
← Mérieux Equity PartnersFirmround
Jun 4, 2026 to presentfactNews and newswire
← KorysFirmround
Jun 4, 2026 to presentfactNews and newswire
← Asabys PartnersFirmround
Jun 4, 2026 to presentfactNews and newswire
← BpifranceFirmround
Jun 4, 2026 to presentfactNews and newswire
← FundPlus NVFirmround
Jun 4, 2026 to presentfactNews and newswire
← Ysios CapitalFirmround
Jun 4, 2026 to presentfactNews and newswire

Dated events

Occurred
Jun 4, 2026
Round announced
Ona Therapeutics announced Series B of $86,600,000
News and newswireobserved 6 days ago
$86.6M

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:dcc008d6-a31a-4904-a317-0d2ae266d60d
First observed: Sep 12, 2026
Last observed: Sep 12, 2026 6 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Ona Therapeutics

series b

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:dcc008d6-a31a-4904-a317-0d2ae266d60d

Data as of Sep 12, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 19, 2026, 6:01 AM UTC and rebuilt at most every 15 minutes.

Announced

Round

Stage

Amount

Basis

Investors

Jun 4, 2026

Series B

Series b

$86.6M

disclosed

n/a

Investor

Class

Fund

Partner

Role

Attribution

Columbus Venture Partners

Candidate VC

n/a

participant

Unknown

Mérieux Equity Partners

Candidate VC

n/a

participant

Unknown

Korys

Candidate VC

n/a

participant

Unknown

Asabys Partners

Candidate VC

n/a

participant

Unknown

Bpifrance

Candidate VC

n/a

participant

Unknown

FundPlus NV

Candidate VC

n/a

participant

Unknown

Ysios Capital

Candidate VC

n/a

participant

Unknown